Literature DB >> 6271017

Sendai virus infection in genetically resistant and susceptible mice.

D G Brownstein, A L Smith, E A Johnson.   

Abstract

The pathogenesis of Sendai virus infection in genetically resistant (C57Bl/6) and susceptible (DBA/2) nonimmune adult mice was investigated. Rising serum complement-fixation (CF) antibody titers were delayed in DBA/2 mice as compared with C57Bl/6 mice. C57Bl/6 mice developed descending desquamative endobronchiolitis, and DBA/2 mice developed descending proliferative endobronchiolitis and bronchogenic alveolitis. Peribronchiolar lymphoid cuffs that formed in C57Bl/6 mice were thicker and more densely populated than those of DBA/2 mice. Immunofluorescence demonstrated viral antigens confined to the epithelial lining of conducting airways in C57Bl/6 mice but extending to alveolar corner cells in DBA/2 mice. Studies with a transmission electron microscope confirmed that Type II pneumocytes were infected only in DBA/2 mice. IgG-containing cells selectively accumulated along the airways of both strains, but fewer were recruited by DBA/2 mice. These results suggest that genetic resistance to Sendai virus is expressed through the immune system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271017      PMCID: PMC1903884     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  THE RESISTANCE OF A2G MICE TO MYXOVIRUSES.

Authors:  J LINDENMANN; C A LANE; D HOBSON
Journal:  J Immunol       Date:  1963-06       Impact factor: 5.422

2.  Studies on the innate resistance of mice to infection with mousepox. I. Resistance and antibody production.

Authors:  K SCHELL
Journal:  Aust J Exp Biol Med Sci       Date:  1960-08

3.  Effect of immunosuppression on the genetic resistance of A2G mice to neurovirulent influenza virus.

Authors:  R A Fiske; P A Klein
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

4.  Susceptibility of inbred and outbred mouse strains to Sendai virus and prevalence of infection in laboratory rodents.

Authors:  J C Parker; M D Whiteman; C B Richter
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

5.  Epithelial and surfactant changes in influenzal pulmonary lesions.

Authors:  S F Stinson; D P Ryan; S Hertweck; J D Hardy; S Y Hwang-Kow; C G Loosli
Journal:  Arch Pathol Lab Med       Date:  1976-03       Impact factor: 5.534

6.  Studies on the immune response and pathogenesis of Sendai virus infection of mice. II. The immunoglobulin class of plasma cells in the bronchial sub-mucosa.

Authors:  G Blandford; R B Heath
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

7.  Parainfluenza virus Sendai infection in macrophages, ependyma, choroid plexus, vascular endothelium and respiratory tract of mice.

Authors:  C A Mims; F A Murphy
Journal:  Am J Pathol       Date:  1973-03       Impact factor: 4.307

8.  The pathogenesis of Sendai virus infection in the mouse lung.

Authors:  T W Robinson; R J Cureton; R B Heath
Journal:  J Med Microbiol       Date:  1968-08       Impact factor: 2.472

9.  Sendai virus replication: an ultrastructural comparison of productive and abortive infections in avian cells.

Authors:  R W Darlington; A Portner; D W Kingsbury
Journal:  J Gen Virol       Date:  1970-12       Impact factor: 3.891

10.  Localization of a protein antigen in the chicken spleen. Effect of various manipulative procedures on the morphogenesis of the germinal centre.

Authors:  R G White; D C Henderson; M B Eslami; K H Neilsen
Journal:  Immunology       Date:  1975-01       Impact factor: 7.397

View more
  17 in total

1.  Pathogenesis of bronchiolitis and pneumonia induced in neonatal and weanling rats by parainfluenza (Sendai) virus.

Authors:  W L Castleman; L J Brundage-Anguish; L Kreitzer; S B Neuenschwander
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

2.  Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice.

Authors:  Makiko Watanabe; Vasiliy P Mishin; Scott A Brown; Charles J Russell; Kelli Boyd; Y Sudhakara Babu; Garry Taylor; Xiaoping Xiong; Xiaowei Yan; Allen Portner; Irina V Alymova
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

3.  Resistance/susceptibility to lethal Sendai virus infection genetically linked to a mucociliary transport polymorphism.

Authors:  D G Brownstein
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Genetic determinants of lung virus titers and resistance to lethal Sendai virus pneumonia.

Authors:  D G Brownstein; S Winkler
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

5.  Assessment of hazard risk associated with the intravenous use of viral vectors in rodents.

Authors:  Jon D Reuter; Xiaoqun Fang; Christina S Ly; Karen K Suter; Daniel Gibbs
Journal:  Comp Med       Date:  2012-10       Impact factor: 0.982

6.  Genetics of natural resistance to Sendai virus infection in mice.

Authors:  D G Brownstein
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

Review 7.  Cellular immunity and memory to respiratory virus infections.

Authors:  D L Woodland; R J Hogan; W Zhong
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

8.  Alterations in pulmonary ultrastructure and morphometric parameters induced by parainfluenza (Sendai) virus in rats during postnatal growth.

Authors:  W L Castleman
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

9.  Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines.

Authors:  John N Mason; Husni Elbahesh; Charles J Russell
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

10.  Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo.

Authors:  Leonid Gitlin; Loralyn Benoit; Christina Song; Marina Cella; Susan Gilfillan; Michael J Holtzman; Marco Colonna
Journal:  PLoS Pathog       Date:  2010-01-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.